Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07693179

Assessment of Prolonged Pain in Infants With Excessive Crying: Contribution of Infrared Thermal Imaging - The NEOTHERM Pilot Study

NEOTHERM is a multicenter, prospective, observational pilot study examining whether infrared thermal imaging (ITI) can contribute to the assessment of prolonged pain in infants with excessive crying. Thermal measurements of the face and body will be compared with scores obtained using the EDIN behavioral pain and discomfort scale. The study will also examine associations between ITI measures, EDIN scores, and hair cortisol concentrations as a biomarker of prolonged stress, and will describe early motor organization and psychomotor development using General Movements Assessment and Bayley-4. Eighty infants will be enrolled in two comparison groups based on daily crying duration and assessed longitudinally at two standardized visits. The main hypothesis is that ITI will identify cutaneous thermal changes associated with prolonged pain and that these measures will be associated with EDIN scores.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

2 week–6 week

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Médico-Psychologique Périnatalité et Petite Enfance Brantôme, Paris, Île-de-France Region, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infants aged 2 to 6 weeks post-term in corrected age at the first assessment.
  • Born at or after 32 weeks' gestational age.
  • No known neurological or gastrointestinal disease.
  • Written informed consent from the holder(s) of parental authority.
  • Meeting the criteria for one of the following two cohorts:
  • Excessive-crying (EC) cohort: crying for more than 3 hours per day on at least 3 consecutive days during the 7 days preceding the assessment (modified Wessel criteria), together with at least two of the following three protocol-specified Rome IV-related features: crying without an apparent cause, inconsolable crying, and associated signs including agitation, facial flushing, clenched fists, and/or flexed legs.
  • Typical-crying (TC) cohort: crying for less than 2 hours per day during the week preceding the assessment.

Infants crying for 2 to 3 hours per day during the week preceding the assessment will not be included in either cohort.

Exclusion criteria

  • Confirmed cerebral lesions identified by ultrasound or magnetic resonance imaging.
  • Major congenital or chromosomal abnormalities.
  • Growth faltering.
  • Birth before 32 weeks' gestational age.
  • Holder(s) of parental authority who do not speak French.
  • Lack of written informed consent from the holder(s) of parental authority.
  • Lack of affiliation with a French social security scheme.
  • Any situation falling under specific legal protection provisions under French law.

Treatment and study plan

Primary outcomes

  1. Association Between Infrared Thermal Imaging Indices and EDIN Total Score

    Time frame: At baseline (T1) and approximately 8 weeks after baseline (T2)

    Mean skin temperatures will be extracted from predefined body and facial regions of interest. Infrared thermal imaging indices will include absolute bilateral body temperature differences, central-to-peripheral temperature gradients, and intra-facial temperature gradients calculated relative to the forehead. An absolute temperature difference greater than 0.5°C will be considered an abnormal thermal asymmetry.

    The EDIN is a behavioral scale assessing facial expression, body movements, sleep, interaction, and consolability. Each item is scored from 0 to 3. Higher scores indicate greater pain- or discomfort-related behaviors; a total score of 5 or higher indicates probable prolonged pain.

    Concordance between infrared thermal imaging indices and EDIN total scores will be quantified using Spearman rank correlation coefficients at each assessment. Thermal images will be analyzed by an external assessor blinded to the EDIN score and cohort classification.

Secondary outcomes

  1. Associations Between Hair Cortisol Concentration, Infrared Thermal Imaging Indices, and EDIN Total Score

    Time frame: At baseline (T1) and approximately 8 weeks after baseline (T2)

    Hair cortisol concentration will be measured in pg/mg of hair from a small sample collected from the occipital region. Cortisol will be quantified using high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS).

    Hair cortisol concentration will be investigated as a biomarker of prolonged stress. Spearman correlation coefficients will be calculated between hair cortisol concentration, infrared thermal imaging indices, and EDIN total scores

  2. General Movements Assessment Scores and Motor Patterns

    Time frame: At baseline (T1); approximately 15, 30, and 45 days after baseline; and approximately 8 weeks after baseline (T2)

    Spontaneous general movements will be recorded with the infant lying supine, wearing only a diaper or onesie, during 2 to 5 minutes of active wakefulness without crying, interaction, a pacifier, or hiccups. Recordings will be independently evaluated by two assessors trained in General Movements Assessment and blinded to cohort classification, EDIN scores, and infrared thermal imaging results.

    The General Movement Optimality Score-Revised (GMOS-R; maximum score 38) will be used at Visit 1. The Motor Optimality Score- Revised (MOS-R) will be used at Visit 2; scores of 25 to 28 are considered optimal, whereas lower scores indicate less optimal motor organization. Qualitative motor characteristics, including movement quality, variability, fluency, symmetry, posture, and atypical movement patterns, will also be described and compared between cohorts.

  3. Psychomotor Development Assessed Using the Bayley Scales of Infant and Toddler Development, Fourth Edition

    Time frame: At baseline (T1) and approximately 8 weeks after baseline (T2)

    Psychomotor development will be assessed using the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4). Five subtests will be administered: cognitive development, receptive communication, expressive communication, fine motor development, and gross motor development.

    Raw subtest scores will be converted to scalar and composite scores using the normative tables of the Bayley-4. Higher scores indicate better performance in the assessed developmental domain. Scores will be compared between the EC and TC cohorts. Scoring will be performed by an assessor blinded to cohort classification.

  4. Associations Between Early Motor Organization and Prolonged Pain or Stress Indicators

    Time frame: From baseline (T1) through approximately 8 weeks after baseline (T2)

    Associations between General Movements characteristics, GMOS-R or MOS scores, Bayley-4 scores, infrared thermal imaging indices, EDIN total scores, and hair cortisol concentrations will be examined using Spearman correlations and exploratory regression analyses.

Study contacts

Contact information is provided by the study sponsor or research team.

Alizée LORI, MD

CONTACT

[email protected]

+33 01 42 35 61 40

Joëlle Provasi, PhD

CONTACT

[email protected]

+33 1 88 12 02 99

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Saint-Denis

Other

Collaborators

  • Ecole Pratique des Hautes Etudes

Registry information

Acronym: NEOTHERM

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jul 9, 2026
Registry last updated
Sep 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.